Logo image of MPW

MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis

NYSE:MPW - New York Stock Exchange, Inc. - US58463J3041 - REIT - Currency: USD

4.07  -0.09 (-2.16%)

After market: 4.08 +0.01 (+0.25%)

Fundamental Rating

3

Overall MPW gets a fundamental rating of 3 out of 10. We evaluated MPW against 130 industry peers in the Diversified REITs industry. Both the profitability and financial health of MPW have multiple concerns. MPW is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MPW has reported negative net income.
In the past year MPW had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MPW reported negative net income in multiple years.
MPW had a positive operating cash flow in each of the past 5 years.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

Looking at the Return On Assets, with a value of -11.13%, MPW is doing worse than 95.38% of the companies in the same industry.
The Return On Equity of MPW (-34.74%) is worse than 93.08% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.88%, MPW is doing worse than 69.23% of the companies in the same industry.
MPW had an Average Return On Invested Capital over the past 3 years of 2.26%. This is in line with the industry average of 3.16%.
Industry RankSector Rank
ROA -11.13%
ROE -34.74%
ROIC 1.88%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

MPW has a Operating Margin of 35.82%. This is in the better half of the industry: MPW outperforms 75.38% of its industry peers.
MPW's Operating Margin has declined in the last couple of years.
MPW has a better Gross Margin (96.89%) than 97.69% of its industry peers.
MPW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.82%
PM (TTM) N/A
GM 96.89%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MPW is destroying value.
MPW has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MPW has more shares outstanding
The debt/assets ratio for MPW is higher compared to a year ago.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.01, we must say that MPW is in the distress zone and has some risk of bankruptcy.
MPW's Altman-Z score of -0.01 is on the low side compared to the rest of the industry. MPW is outperformed by 76.92% of its industry peers.
MPW has a Debt/Equity ratio of 1.99. This is a high value indicating a heavy dependency on external financing.
MPW has a Debt to Equity ratio of 1.99. This is in the lower half of the industry: MPW underperforms 71.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.99
Debt/FCF N/A
Altman-Z -0.01
ROIC/WACC0.31
WACC6.08%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

MPW has a Current Ratio of 2.38. This indicates that MPW is financially healthy and has no problem in meeting its short term obligations.
MPW's Current ratio of 2.38 is amongst the best of the industry. MPW outperforms 83.85% of its industry peers.
A Quick Ratio of 2.38 indicates that MPW has no problem at all paying its short term obligations.
MPW has a better Quick ratio (2.38) than 83.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 2.38
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

MPW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1304.35%.
The Revenue has grown by 19.56% in the past year. This is quite good.
The Revenue has been growing slightly by 3.11% on average over the past years.
EPS 1Y (TTM)-1304.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.71%
Revenue 1Y (TTM)19.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-17.51%

3.2 Future

MPW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.85% yearly.
MPW is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.37% yearly.
EPS Next Y98.32%
EPS Next 2Y43.72%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue Next Year-2.95%
Revenue Next 2Y1.89%
Revenue Next 3Y2.92%
Revenue Next 5Y-0.37%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MPW. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 23.47, which indicates a rather expensive current valuation of MPW.
82.31% of the companies in the same industry are more expensive than MPW, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of MPW to the average of the S&P500 Index (35.33), we can say MPW is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 23.47
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MPW is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.45
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MPW's earnings are expected to grow with 27.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.72%
EPS Next 3Y27.85%

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.67%, MPW is a good candidate for dividend investing.
The stock price of MPW dropped by -25.32% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
MPW's Dividend Yield is a higher than the industry average which is at 6.44.
Compared to an average S&P500 Dividend Yield of 2.35, MPW pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.67%

5.2 History

The dividend of MPW decreases each year by -10.38%.
MPW has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MPW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-16.72%
EPS Next 2Y43.72%
EPS Next 3Y27.85%
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

More info and screens

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (7/15/2025, 7:26:53 PM)

After market: 4.08 +0.01 (+0.25%)

4.07

-0.09 (-2.16%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners60.69%
Inst Owner Change-0.01%
Ins Owners17.33%
Ins Owner Change10.75%
Market Cap2.45B
Analysts52.22
Price Target5.32 (30.71%)
Short Float %35.27%
Short Ratio20.01
Dividend
Industry RankSector Rank
Dividend Yield 7.67%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-16.72%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-18 2025-06-18 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6414.34%
Min EPS beat(2)-11757.5%
Max EPS beat(2)-1071.21%
EPS beat(4)0
Avg EPS beat(4)-3998.5%
Min EPS beat(4)-11757.5%
Max EPS beat(4)-653.07%
EPS beat(8)1
Avg EPS beat(8)-1972.17%
EPS beat(12)3
Avg EPS beat(12)-1334.35%
EPS beat(16)6
Avg EPS beat(16)-987.1%
Revenue beat(2)1
Avg Revenue beat(2)0.96%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)5.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)5.9%
Revenue beat(8)3
Avg Revenue beat(8)-1.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.93%
Revenue beat(16)6
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)-5.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)154.56%
EPS NY rev (1m)-214.29%
EPS NY rev (3m)40%
Revenue NQ rev (1m)-0.82%
Revenue NQ rev (3m)1.56%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)1.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.47
P/S 2.58
P/FCF N/A
P/OCF 14.26
P/B 0.51
P/tB 0.51
EV/EBITDA 14.45
EPS(TTM)-2.77
EYN/A
EPS(NY)0.17
Fwd EY4.26%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.29
OCFY7.01%
SpS1.58
BVpS7.92
TBVpS7.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.13%
ROE -34.74%
ROCE 2.38%
ROIC 1.88%
ROICexc 1.98%
ROICexgc 2.05%
OM 35.82%
PM (TTM) N/A
GM 96.89%
FCFM N/A
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexcg growth 3Y-18.25%
ROICexcg growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.99
Debt/FCF N/A
Debt/EBITDA 12.11
Cap/Depr 49.98%
Cap/Sales 23.3%
Interest Coverage 0.84
Cash Conversion 21.95%
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 2.38
Altman-Z -0.01
F-Score5
WACC6.08%
ROIC/WACC0.31
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1304.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.71%
EPS Next Y98.32%
EPS Next 2Y43.72%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue 1Y (TTM)19.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-17.51%
Revenue Next Year-2.95%
Revenue Next 2Y1.89%
Revenue Next 3Y2.92%
Revenue Next 5Y-0.37%
EBIT growth 1Y1491.35%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year124.47%
EBIT Next 3Y38.21%
EBIT Next 5YN/A
FCF growth 1Y31.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-75.33%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%